CIBC World Markets’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$821K Buy
+8,040
New +$719K ﹤0.01% 759
2025
Q2
$1.14M Sell
15,115
-12,138
-45% -$542K 0.01% 647
2025
Q1
$1.81M Buy
27,253
+15,911
+140% +$686K 0.01% 522
2024
Q4
$597K Buy
+11,342
New +$319K ﹤0.01% 689
2021
Q2
Sell
-434
Closed -$244K 744
2021
Q1
$244K Buy
+434
New +$65.6K ﹤0.01% 975
2020
Q1
Sell
-4,007
Closed -$2.56M 638
2019
Q4
$2.56M Buy
+4,007
New +$289K 0.02% 537

Other funds holding GH

CIBC World Markets's GH Position: Q4 2025 in Review

CIBC World Markets opened a new position in Guardant Health (GH) in Q4 2025: 8,040 shares worth $821K. The stake represents ﹤0.01% of the portfolio and ranks #759 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in GH as recently as Q2 2025.

CIBC World Markets first reported a position in GH in Q4 2019 and has held it in 6 quarters since. The position peaked at $2.56M in Q4 2019. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • CIBC World Markets held 8,040 shares of Guardant Health worth $821K as of Q4 2025.
  • Guardant Health was a new CIBC World Markets position in Q4 2025.
  • Guardant Health made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #759 holding.
  • CIBC World Markets first reported a position in Guardant Health in Q4 2019 and has held it in 6 quarters since.
  • CIBC World Markets's Guardant Health position peaked at $2.56M in Q4 2019.
  • 497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.